Klinik und Poliklinik für Nuklearmedizin

Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [²²³Ra]RaCl₂ therapy
Sraieb, Miriam; Hirmas, Nader; Conrad, Rupert; Marinova, Milka; Essler, Markus; Herrmann, Ken; Ahmadzadehfar, Hojjat (2020-08-19)
[<sup>223</sup>Ra]RaCl<sub>2</sub> dichloride treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) is associated with improved overall survival (OS) and a delay in the time to the first ...